Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.14 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)
Fever, a physiological response to infection or inflammation, has intrigued medical practitioners for centuries. In this abstract, we delve into the comparative analysis of three distinct febrile conditions: Pyrexia, Jwaara, and COVID-19. Pyrexia, a term derived from Greek, denotes elevated body temperature. Jwaara, originating from ancient Indian Ayurveda, encompasses fever as a manifestation of bodily imbalance. COVID-19, caused by the novel coronavirus SARS-CoV-2, has become a global health crisis, often presenting with fever as a primary symptom.
Pyrexia, as understood in modern medicine, is a regulated response mediated by cytokines such as interleukin-1 (IL-1) and tumor necrosis factor-alpha (TNF-α), triggered by pyrogens. It serves a crucial role in combating pathogens by enhancing immune responses. Jwaara, on the other hand, is conceptualized within Ayurveda as an imbalance in the body's doshas—vata, pitta, and kapha—resulting in derangement of bodily functions, including thermoregulation. Ayurvedic texts classify fever into various types based on etiology, symptoms, and affected bodily systems, offering a holistic approach to its management.
In contrast, COVID-19-induced fever presents unique challenges due to the pathophysiological mechanisms of the SARS-CoV-2 virus. Besides the classical symptoms of fever, patients often exhibit respiratory distress and multi-organ involvement, reflecting the systemic nature of the disease. The hyperinflammatory response, characterized by cytokine storm syndrome, contributes to the severity of COVID-19 fever and its complications.
Despite their differences, these febrile conditions share commonalities in clinical manifestations and management strategies. Differential diagnosis remains crucial, considering the diverse etiologies and potential complications associated with each condition. While antipyretics provide symptomatic relief in all three cases, targeted therapies tailored to the underlying pathophysiology are imperative for optimal outcomes, especially in severe or refractory cases.
In this article am trying to correlate jwara with pyrexia and covid 19 , and the management of jwara chikitsa for treating pyrexia and covid 19.
Keywords:
Jwara, Covid19, Pyrexia, Management
Cite Article:
"Comparative Analysis of Pyrexia, Jwaara, and COVID-19: Insights into Fever Phenomena", International Journal of Science & Engineering Development Research (www.ijrti.org), ISSN:2455-2631, Vol.9, Issue 4, page no.512 - 516, April-2024, Available :http://www.ijrti.org/papers/IJRTI2404073.pdf
Downloads:
000205102
ISSN:
2456-3315 | IMPACT FACTOR: 8.14 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.14 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator